Seth L. Sherman, MD
Stanford University
Disclosure(s): Allosource: Speaker (Ongoing); Arcuro Medical: Consultant (Ongoing), Paid Advisor (Ongoing); Arthrex: Consultant (Ongoing); ConMed: Royalties (Ongoing); DJO: Royalties (Ongoing); Epicrispr BioTech: Own stock options in a privately held ineligible company (Ongoing); Icarus: Own stock options in a privately held ineligible company (Ongoing); JRF Ortho: Speaker (Ongoing); Kinamed: Speaker (Ongoing); Kyniska Robotics: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); LifeNet Health: Consultant (Ongoing); MIACH: Speaker (Ongoing); MoxImed: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Octane Biotherapeutics: Speaker (Ongoing); Organogenesis: Speaker (Ongoing); Ossio: Speaker (Ongoing); Reparel: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Sarcio Inc: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Smith & Nephew: Speaker (Ongoing); Sparta Biomedical: Consultant (Ongoing), Paid Advisor (Ongoing); Sparta-Bioenthesis: Own stock options in a privately held ineligible company (Ongoing); Vericel: Consultant (Ongoing); Vivorte: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing)